{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"short-stature-due-to-primary-acid-labile-subunit-deficiency","columns":[{"gene":"","key":"population-634c2797711b106af032","label":"Acid-labile subunit, deficiency of","mondoId":"MONDO:0014420","onsetQualifier":null,"originColumnKey":"MONDO:0014420/OMIM:615961","originalViews":[{"key":"MONDO:0014420/OMIM:615961","label":"Acid-labile subunit, deficiency of","scopeLabel":"OMIM:615961","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1704c4431d35bdb34ef04a7fe7df07bf8f448321ad0d683dd0a39111559268a3","70d4227e70715ffd06839596aa8678e2b825e36a7019d404ff04c65c1b794c21","ab0a617965403b3e6f43fe39ca8d4a48bc16c4cd2c45a076e226b55a676b160a","b8b9ec385af1f9d2fd1a97e0852ffe4df80978d3920d951197fc081aced52235","ec105ccf87d0bc6cc56b978b6966a0bc9493566476ae571957ebeac4da1b9650"],"recordQualifiers":{},"scopeLabel":"OMIM:615961","sourceIds":["OMIM:615961"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-b3bf4c97596e453e59e6","label":"Short stature due to primary acid-labile subunit deficiency","mondoId":"MONDO:0014420","onsetQualifier":null,"originColumnKey":"MONDO:0014420/ORPHA:140941","originalViews":[{"key":"MONDO:0014420/ORPHA:140941","label":"Short stature due to primary acid-labile subunit deficiency","scopeLabel":"ORPHA:140941","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0d1920f37750a75bcea9fdcd4ccf8468baf0a166354a9cc2ff6cd7dd3b0e21dc","2b60ca3a71efec350f33e153096fb8a55207d769016003a57a8c405bc0daf886","7ab5800e5874e2945183aeb70d40d2f126b42c0eb097e32e1d144a0fba6cd111","ac0b146b5525c840cec7f9a2f3a254771958219ae3b7ec2048717b2299da1664","be80b7148ff2b3aaa1d85ea439418d14caaec5ce01fdced123bcf4e64af16c45","d818606d71fab361cb0fc37739baff3fe45b848f62fd2510c99973d3bdc29fae","fc700b88a47877bb3c70895f00d82f2332d38229e2de13694421e7cd04a2635f"],"recordQualifiers":{},"scopeLabel":"ORPHA:140941","sourceIds":["ORPHA:140941"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-634c2797711b106af032","population-b3bf4c97596e453e59e6"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0030353","HP:0045046","HP:0000823","HP:0002750","HP:0001510","HP:0008189","HP:0000855"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":7,"published":5}},"features":[{"hpoId":"HP:0030353","label":"Decreased circulating insulin-like growth factor 1 concentration","primary":true},{"hpoId":"HP:0045046","label":"Decreased circulating insulin-like growth factor-binding protein acid labile subunit concentration","primary":true},{"hpoId":"HP:0000823","label":"Delayed puberty","primary":true},{"hpoId":"HP:0002750","label":"Delayed skeletal maturation","primary":true},{"hpoId":"HP:0001510","label":"Growth delay","primary":true},{"hpoId":"HP:0008189","label":"Insulin insensitivity","primary":true},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":true},{"hpoId":"HP:0000347","label":"Micrognathia","primary":false},{"hpoId":"HP:0001530","label":"Mild postnatal growth retardation","primary":false},{"hpoId":"HP:0001956","label":"Truncal obesity","primary":false}],"ledeHtml":"Short stature due to primary acid-labile subunit (ALS) deficiency is characterized by moderate postnatal growth deficit, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), and hyperinsulinemia, in the absence of growth hormone (GH) deficiency or GH insensitivity.","mondoId":"MONDO:0014420","node":{"canonicalSlug":"short-stature-due-to-primary-acid-labile-subunit-deficiency","comparisons":[{"documentSha256":"a8009adacdf6133a313df87ac164de6c1fd3ce63c8609c9a2a0d0aeb1dac4f46","key":"legacy-short-stature-due-to-primary-acid-labile-subunit-deficiency","kind":"legacy","label":"short stature due to primary acid-labile subunit deficiency","memberIds":["MONDO:0014420"],"mondoId":"MONDO:0014420","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/short-stature-due-to-primary-acid-labile-subunit-deficiency.a8009adacdf6133a313df87ac164de6c1fd3ce63c8609c9a2a0d0aeb1dac4f46.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Short stature due to primary acid-labile subunit deficiency","originalSourceId":"ORPHA:140941","paragraphs":["Short stature due to primary acid-labile subunit (ALS) deficiency is characterized by moderate postnatal growth deficit, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), and hyperinsulinemia, in the absence of growth hormone (GH) deficiency or GH insensitivity."],"rawAttribution":"MONDO:0014420","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:01:43Z","upstream":"MONDO:0014420","url":"https://rarediseases.info.nih.gov/diseases/16964"},"ownColumnKeys":["population-634c2797711b106af032","population-b3bf4c97596e453e59e6"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"growth hormone insensitivity syndrome","mondoId":"MONDO:0015892","slug":"growth-hormone-insensitivity"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0d1920f37750a75bcea9fdcd4ccf8468baf0a166354a9cc2ff6cd7dd3b0e21dc","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001956","is_excluded":false,"label":"Truncal obesity","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1704c4431d35bdb34ef04a7fe7df07bf8f448321ad0d683dd0a39111559268a3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:615961","disease_name":"Acid-labile subunit, deficiency of","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0030353","is_excluded":false,"label":"Decreased circulating insulin-like growth factor 1 concentration","onset_id":null,"reference":"PMID:21396577","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"2b60ca3a71efec350f33e153096fb8a55207d769016003a57a8c405bc0daf886","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000823","is_excluded":false,"label":"Delayed puberty","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"70d4227e70715ffd06839596aa8678e2b825e36a7019d404ff04c65c1b794c21","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615961","disease_name":"Acid-labile subunit, deficiency of","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0008189","is_excluded":false,"label":"Insulin insensitivity","onset_id":null,"reference":"PMID:21396577","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7ab5800e5874e2945183aeb70d40d2f126b42c0eb097e32e1d144a0fba6cd111","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002750","is_excluded":false,"label":"Delayed skeletal maturation","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ab0a617965403b3e6f43fe39ca8d4a48bc16c4cd2c45a076e226b55a676b160a","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:615961","disease_name":"Acid-labile subunit, deficiency of","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001530","is_excluded":false,"label":"Mild postnatal growth retardation","onset_id":null,"reference":"PMID:21396577","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ac0b146b5525c840cec7f9a2f3a254771958219ae3b7ec2048717b2299da1664","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030353","is_excluded":false,"label":"Decreased circulating insulin-like growth factor 1 concentration","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b8b9ec385af1f9d2fd1a97e0852ffe4df80978d3920d951197fc081aced52235","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:615961","disease_name":"Acid-labile subunit, deficiency of","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000823","is_excluded":false,"label":"Delayed puberty","onset_id":null,"reference":"PMID:21396577","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"be80b7148ff2b3aaa1d85ea439418d14caaec5ce01fdced123bcf4e64af16c45","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d818606d71fab361cb0fc37739baff3fe45b848f62fd2510c99973d3bdc29fae","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000347","is_excluded":false,"label":"Micrognathia","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ec105ccf87d0bc6cc56b978b6966a0bc9493566476ae571957ebeac4da1b9650","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615961","disease_name":"Acid-labile subunit, deficiency of","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0045046","is_excluded":false,"label":"Decreased circulating insulin-like growth factor-binding protein acid labile subunit concentration","onset_id":null,"reference":"PMID:14762184","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fc700b88a47877bb3c70895f00d82f2332d38229e2de13694421e7cd04a2635f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:140941","disease_name":"Short stature due to primary acid-labile subunit deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:140941","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16964\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014420\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0014420</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Short stature due to primary acid-labile subunit (ALS) deficiency is characterized by moderate postnatal growth deficit, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), and hyperinsulinemia, in the absence of growth hormone (GH) deficiency or GH insensitivity.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16964\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"short-stature-due-to-primary-acid-labile-subunit-deficiency","sourceDocuments":[{"name":"GARD: Short stature due to primary acid-labile subunit deficiency","reviewed":null,"source_release":"2026-10-21T17:01:43Z","url":"https://rarediseases.info.nih.gov/diseases/16964"},{"name":"MONDO: short stature due to primary acid-labile subunit deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014420"}],"sourceNote":"","synonyms":["acid-labile SUBUNIT deficiency","acid-labile subunit, deficiency of","ACLSD"],"takeawayHtml":"","title":"short stature due to primary acid-labile subunit deficiency"},"schemaVersion":1}
